The FDA’s Move Towards More Transparent, Collaborative Approval Process Requires Robust Compliance Management Systems
In a recent article posted on Pharmaceutical Compliance Monitor, Dr. Frank Gozzo, president and CEO of Noverant, discusses the FDA’s move towards a more transparent and collaborative approval process. He explains why this change is being made and how it requires companies within the pharmaceutical industry to maintain robust compliance management systems. To learn more about why strong compliance engines are important and the impact that they can have on developing a cooperative relationship between manufacturers and…
Noverant Inks Deal With PRIDE Industries
RALEIGH, N.C. – Dr. Frank Gozzo, president and CEO of Noverant, Inc., has announced that the company has been selected by PRIDE Industries to provide a comprehensive learning management system (LMS) for its operation. PRIDE Industries is a major employer serving Fortune 500, state, Federal and military agencies in areas including manufacturing, supply chain, logistics and facility services. The organization has more than 4,000 employees nationwide and selected Noverant to provide a complete enterprise-wide training,…